Genesys Capital leverages strong exit multiples in launch of $150 mln Fund III
Genesys Capital has launched its third life sciences venture fund on the strength of several recent portfolio wins, including the public debut of medical device provider Profound Medical. Genesys Ventures III LP hit the fundraising trail in April, targeting $150 million in committed capital. That’s more than twice the size of its predecessor, which closed in 2007.
15 June 2015•3 mins read
